Welcome to our dedicated page for Chiron Real Estate SEC filings (Ticker: XRN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Chiron Real Estate's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Chiron Real Estate's regulatory disclosures and financial reporting.
Chiron Real Estate Inc. director Lori Wittman reported an open-market purchase of 2,940 shares of Common Stock. The shares were bought at an average price of $33.8487 per share, and following this transaction she holds 2,940 shares directly.
Chiron Real Estate Inc. director Marston Ronald reported multiple open-market purchases of common stock for trust accounts. On May 12, 2026, trusts associated with him bought a total of 1,500 shares at prices around $34 per share, increasing indirect holdings in each account. After these transactions, the respective trust accounts held 3,066, 2,766, and 1,755 shares of common stock. The shares are reported on a post-split basis following the company’s 1-for-5 reverse stock split completed on September 19, 2025.
Chiron Real Estate Inc. insider Barber Jamie Allen, the company’s General Counsel and Secretary, reported an open-market purchase of Common Stock. An individual retirement account associated with Barber bought 1,481 shares at $33.50 per share and now holds 1,481 shares indirectly.
Chiron Real Estate Inc.’s CFO and Treasurer, Robert J. Kiernan, purchased 3,000 shares of Common Stock in an open-market transaction at $33.49 per share. Following this buy on May 11, 2026, he directly holds a total of 6,000 Chiron Real Estate shares.
Chiron Real Estate Inc. COO Holley Danica made an open-market purchase of 1,490 shares of common stock. The weighted average purchase price was about $33.99 per share, with individual trades between $33.96 and $34.00. After this transaction, her direct holdings total 1,590 shares, which includes 100 shares originally bought in the company’s 2016 initial public offering and adjusted for a 1-for-5 reverse stock split that took effect on September 19, 2025.
Chiron Real Estate Inc. director and CEO/President Decker Mark Okey Jr reported fresh insider buying of the company’s common stock. On May 12, 2026, he made two open-market purchases totaling 5,000 shares, buying 4,000 shares at $33.99 per share and 1,000 shares at $33.74 per share. After these transactions, his directly held common stock position increased to 59,774 shares, and an additional 3,404 shares are reported as indirectly owned through his spouse.
Chiron Real Estate Inc. director Paula Crowley reported an open-market purchase of 1,000 shares of common stock at $34.00 per share. The shares are held indirectly through a revocable trust, which now holds a total of 1,000 shares following this transaction.
Chiron Real Estate Inc. director Cole Henry, through a living trust, reported two open-market purchases of Common Stock on May 11, 2026. The trust bought 575 shares at $34.315 per share and 8 shares at $33.355 per share, for a net acquisition of 583 shares. After these trades, the filing shows indirect trust holdings of 2,129 shares and 1,554 shares in the respective accounts. A footnote notes that the share amounts reflect a prior 1-for-5 reverse stock split completed on September 19, 2025.
Chiron Real Estate Inc. entered into an investment agreement with Maewyn XRN LP and other purchasers for a private placement of up to $100.0 million of new 6.00% Series C Convertible Perpetual Preferred Stock.
The company may sell up to 1,000,000 Series C shares at $100.00 per share in tranches, with an initial funding of at least $25.0 million expected to close on or before June 20, 2026. The preferred stock carries a 6.00% cash dividend that can step up over time, ranks senior to common stock, and is convertible into common stock at an initial implied price of $43.00 per share, subject to anti-dilution and 19.9% ownership caps before stockholder approval.
Chiron will pay a 3% commitment fee on the $100.0 million commitment and reimburse up to $250,000 of investor legal fees, and expects to use proceeds for general business, working capital and potential acquisitions. Maewyn receives board nomination, consent and standstill rights, while holders gain registration rights and warrants in certain redemption scenarios.
Chiron Real Estate Inc. reported first-quarter 2026 rental revenue of $38.1 million, up from $34.6 million a year earlier, driven by its 189-building healthcare portfolio. Net income was $1.7 million, down from $3.7 million, as higher operating, G&A and non-cash depreciation and amortization offset revenue growth.
After paying $2.5 million of preferred dividends, common stockholders recorded a net loss of $0.06 per share versus earnings of $0.16 a year ago. Operating cash flow remained solid at $13.4 million, while net real estate investments stayed near $1.5 billion and Credit Facility borrowings totaled $672.0 million.
Subsequent to quarter end, Chiron agreed to acquire three luxury seniors housing communities totaling $425 million in Alexandria and North Bethesda, to be run as operating properties. It also arranged an up to $100 million delayed-draw Series C convertible preferred investment and reduced its quarterly common dividend by about 36% to prioritize funding this growth strategy.